CBD Gummies for Breathing: What to Know Before Trying Them
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdRespiratoryPatient EducationEvidence…
CBD Gummies Sexuality: What the Evidence Shows for Libido, Relaxation, and Intimacy
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Sexual HealthCbdAnxietyEvidence GapPatient…
Targeting of ibrutinib resistance–driving pathways by miR-28 in ABC-DLBCL – Nature
This study investigates ibrutinib resistance mechanisms in ABC-DLBCL, focusing on the role of miR-28. Understanding these pathways is crucial for advancing lymphoma treatment. The research highlights potential targets to overcome drug resistance.
Treating Cyclic Vomiting and Cannabinoid Hyperemesis: What the Evidence (and Experts) Currently Support
More research is needed to develop evidence-based, individualized abortive treatment plans, as well as to determine whether the abortive treatment for CVS requires a fundamentally different approach than for CHS.
Only Five Trials Found: Cannabinoids for Post-Surgery Pain Remain an Open Question
The focus on cannabinoids acute postoperative pain reveals only five trials with contradictory results. This scarcity of data prevents meta-analytic evaluations and clinical recommendations. More standardized research is essential to clarify their role…
CBD Chewing Gum: Promising Concept, Thin Evidence
CBD chewing gum drug delivery is a promising concept with limited clinical evidence. Research gaps remain in absorption mechanisms, dosing precision, and long-term safety. Current trials show no significant efficacy over placebo.
Medical Cannabis for Arthritis Pain: What the Evidence Really Shows
Despite promising preclinical and observational evidence that MC and cannabis-derived compounds are useful in the management of rheumatic disease-related pain, there remains limited high-quality clinical evidence to substantiate these findings.
Medical Cannabis in Older Adults: Promising Interest, Thin Evidence
Evidence of efficacy for relief of an array of symptoms is overall scanty, and almost all study participants are aged < 60 years. The risk of known and potential adverse effects is considerable, with concerns for cognitive, cardiovascular and gait and…
Older Adults and Medical Cannabis: Promising Interest, Scarce Evidence
Evidence of efficacy for relief of an array of symptoms is overall scanty, and almost all study participants are aged < 60 years. The risk of known and potential adverse effects is considerable, with concerns for cognitive, cardiovascular and gait and…